Does MACITENTAN Cause Infusion site induration? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Infusion site induration have been filed in association with MACITENTAN (OPSYNVI). This represents 0.1% of all adverse event reports for MACITENTAN.
26
Reports of Infusion site induration with MACITENTAN
0.1%
of all MACITENTAN reports
0
Deaths
10
Hospitalizations
How Dangerous Is Infusion site induration From MACITENTAN?
Of the 26 reports, 10 (38.5%) required hospitalization.
Is Infusion site induration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MACITENTAN. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does MACITENTAN Cause?
Dyspnoea (8,315)
Death (5,864)
Headache (4,856)
Diarrhoea (3,669)
Pneumonia (3,531)
Nausea (3,463)
Hospitalisation (3,414)
Fatigue (3,172)
Fluid retention (2,861)
Dizziness (2,704)
What Other Drugs Cause Infusion site induration?
TREPROSTINIL (598)
HUMAN IMMUNOGLOBULIN G (209)
FOSCARBIDOPA\FOSLEVODOPA (112)
AMBRISENTAN (49)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (25)
CAPECITABINE (23)
EVEROLIMUS (22)
ZOLEDRONIC ACID (22)
PAMIDRONATE (20)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (17)
Which MACITENTAN Alternatives Have Lower Infusion site induration Risk?
MACITENTAN vs MACITENTAN\TADALAFIL
MACITENTAN vs MAGNESIUM
MACITENTAN vs MAGNESIUM ASPARTATE
MACITENTAN vs MAGNESIUM ASPARTATE\POTASSIUM ASPARTATE
MACITENTAN vs MAGNESIUM HYDROXIDE